Vanguard Group Portfolio holdings
AUM
$6.9T
Turnover
4.07%
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$6.18T
AUM Growth
+$647B
(+12%)
Cap. Flow
+$78.1B
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
28.81%
Holding
4,383
New
103
Increased
2,425
Reduced
1,410
Closed
108
Avg Time Held
8.1
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.95B |
| 2 |
NVIDIA
NVDA
|
+$4.97B |
| 3 |
Capital One
COF
|
+$4.5B |
| 4 |
Amazon
AMZN
|
+$3.45B |
| 5 |
Flutter Entertainment
FLUT
|
+$3.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Discover Financial Services
DFS
|
+$5.32B |
| 2 |
Intra-Cellular Therapies Inc.
ITCI
|
+$1.26B |
| 3 |
Amphenol
APH
|
+$1.18B |
| 4 |
Welltower
WELL
|
+$987M |
| 5 |
US Steel
X
|
+$825M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.14% |
| 2 | Financials | 14% |
| 3 | Consumer Discretionary | 10.14% |
| 4 | Healthcare | 9.38% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3826
Good Times Restaurants
GTIM
$14.9M
| $747K | ﹤0.01% |
417,401
| – | – |
2013 Q3
47 quarters
|
|
3827
Critical Metals Corp
CRML
$920M
| $744K | ﹤0.01% |
207,879
+152,726
| +277% | +$278K |
2024 Q2
4 quarters
|
|
3828
SPDR Gold Trust
GLD
$138B
| $743K | ﹤0.01% |
2,439
| – | – |
2023 Q1
9 quarters
|
|
3829
RAVE Restaurant Group
RAVE
$30.8M
| $741K | ﹤0.01% |
269,530
+10,857
| +4% | +$27.4K |
2013 Q2
48 quarters
|
|
3830
Vanguard Financials ETF
VFH
$12.9B
| $740K | ﹤0.01% |
5,811
+208
| +4% | +$24.8K |
2023 Q2
8 quarters
|
|
3831
Clene
CLNN
$46.5M
| $736K | ﹤0.01% |
188,357
+55,023
| +41% | +$179K |
2021 Q1
17 quarters
|
|
3832
DELISTED
Generation Bio
GBIO
| $735K | ﹤0.01% |
229,835
-32,136
| -12% | -$124K |
2020 Q2
20 quarters
|
|
3833
Brilliant Earth
BRLT
$23.7M
| $733K | ﹤0.01% |
534,937
| – | – |
2021 Q3
15 quarters
|
|
3834
Lisata Therapeutics
LSTA
$11.3M
| $732K | ﹤0.01% |
254,182
| – | – |
2013 Q2
48 quarters
|
|
3835
Donegal Group Class B
DGICB
$680M
| $725K | ﹤0.01% |
41,332
+21,000
| +103% | +$363K |
2022 Q4
10 quarters
|
|
|
AIFA
3836
All In FutureTech Alliance Inc
AIFA
$27.4M
| $724K | ﹤0.01% |
46,588
+4,274
| +10% | +$49.7K |
2020 Q3
19 quarters
|
|
3837
DELISTED
KORE Group Holdings
KORE
| $723K | ﹤0.01% |
302,681
| – | – |
2021 Q4
14 quarters
|
|
3838
Giftify Inc
GIFT
$22.6M
| $718K | ﹤0.01% |
478,580
+316,323
| +195% | +$539K |
2024 Q4
2 quarters
|
|
3839
Protalix BioTherapeutics
PLX
$222M
| $718K | ﹤0.01% |
+484,798
| New | +$992K |
2025 Q2
0 quarters
|
|
3840
iShares MSCI USA Quality Factor ETF
QUAL
$48.6B
| $717K | ﹤0.01% |
3,923
+293
| +8% | +$50.6K |
2024 Q1
5 quarters
|
|
3841
NanoViricides
NNVC
$33.9M
| $715K | ﹤0.01% |
510,416
| – | – |
2013 Q4
46 quarters
|
|
3842
Lipocine
LPCN
$13.7M
| $711K | ﹤0.01% |
224,876
-1,400
| -0.6% | -$4.54K |
2014 Q3
43 quarters
|
|
3843
Newsmax Inc
NMAX
$1.21B
| $709K | ﹤0.01% |
+46,877
| New | +$1.23M |
2025 Q2
0 quarters
|
|
3844
DELISTED
BIOATLA INC
BCAB
| $706K | ﹤0.01% |
35,663
-697
| -2% | -$14.1K |
2020 Q4
18 quarters
|
|
3845
Acrivon Therapeutics
ACRV
$74.1M
| $706K | ﹤0.01% |
593,247
-81,543
| -12% | -$112K |
2023 Q1
9 quarters
|
|
3846
Curis
CRIS
$1.45M
| $703K | ﹤0.01% |
15,160
| – | – |
2013 Q2
48 quarters
|
|
3847
Optical Cable Corp
OCC
$130M
| $703K | ﹤0.01% |
246,727
+13,406
| +6% | +$38.6K |
2013 Q2
48 quarters
|
|
3848
Hydrofarm Holdings
HYFM
$3.76M
| $702K | ﹤0.01% |
187,616
| – | – |
2020 Q4
18 quarters
|
|
3849
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $687K | ﹤0.01% |
90,205
| – | – |
2021 Q2
16 quarters
|
|
3850
DELISTED
Nine Energy Service
NINE
| $685K | ﹤0.01% |
888,741
| – | – |
2018 Q1
29 quarters
|
|
Similar funds
CWM
FAF
BGIM
CIM
UOC
Vanguard Group's Q2 2025 Portfolio in Review
As of Q2 2025, Vanguard Group held 4,383 positions worth $6.18T, up 12% from $5.53T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 4.8%. Vanguard Group opened 103 new positions and exited 108, leaving the 4,383-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q2 2025 buy was Amrize Ltd: 21,350,540 shares worth $1.07B.
- Vanguard Group added most to Microsoft in Q2 2025, an estimated $5.95B increase.
- Vanguard Group's biggest Q2 2025 reduction was Amphenol, cutting an estimated $1.18B.
- Vanguard Group fully exited Discover Financial Services in Q2 2025, selling an estimated $5.32B.
- Vanguard Group's ten largest holdings make up 29% of its $6.18T portfolio in Q2 2025.
- Vanguard Group opened 103 new positions and closed 108 in Q2 2025.
- Vanguard Group's portfolio value rose 12% quarter-over-quarter to $6.18T.
Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.